ABSTRACT
OBJECTIVES: To determine the 99th percentile upper reference limit (URL) of high-sensitivity cardiac troponin I (hs-cTnI) in a healthy population in Xinjiang, China, and investigate the impact of ethnicity, sex, and age on this limit. DESIGN AND METHODS: From September 2018 to March 2022, 5,090 Han and Uyghur adults aged 20-79 years were recruited. After questionnaire screening, 2,970 participants with physical and/or laboratory normality were enrolled. Participants recruited between September 2018 and October 2021 (2,109/2,970) were evaluated by ARCHITECTi2000 to determine the 99th percentile URL of hs-cTnI. The results were then validated in 861/2,970 participants recruited from November 2021 to March 2022. A criterion of ≤ 10% of test results falling outside the original determined value was used to determine whether the newly established reference intervals were valid. RESULTS: The hs-cTnI concentration was higher among Uyghurs than among Han participants (p < 0.001). The 99th percentile URLs were 17.52 ng/L for all participants, 18.96 ng/L for Uyghur, and 16.93 ng/L for Han. Hs-cTnI concentration was also correlated with sex and age. In the Han and Uyghur groups, male participants had a higher hs-cTnI concentration than female participants (p < 0.001); the 99th percentile URLs of hs-cTnI among male and female participants were 17.80 vs. 13.67 ng/L and 19.47 vs. 16.52 ng/L, respectively. Stratified by age, hs-cTnI concentrations were higher in participants aged > 60 years than in those of other age categories (p < 0.001), in both the Han and Uyghur groups. Finally, <2% of these test results exceeded the newly established reference, validating the results. CONCLUSIONS: This study established the 99th percentile URLs of hs-cTnI in the Xinjiang. Ethnicity and sex influence the value and should be considered.
Subject(s)
Ethnicity , Troponin I , Adult , Humans , Male , Female , Middle Aged , Reference Values , China , Laboratories , Troponin T , BiomarkersABSTRACT
Pseudomonas putida ND6 was shown to be capable of growth using naphthalene as sole carbon and energy sources. One plasmid from this strain, pND6-1, which was associated with the metabolism of naphthalene, was characterized; and the complete nucleotide sequence (101,858bp) and annotation of the plasmid were reported previously. In this paper, another plasmid (117,003bp) from P. putida ND6, pND6-2, was sequenced and 136 putative coding sequences (CDSs) were annotated. Among them, 9 CDSs were predicted to be involved in replication and partition of the plasmid, 32 CDSs encoded proteins associated with plasmid conjugative transfer, 2 CDSs encoded transcriptional regulators, 9 CDSs were necessary for DNA-associated function (including metabolism, recombination and repair), and 5 CDSs encoded proteins associated with other functions. The filter matting experiment indicated that pND6-2 is a helper plasmid, which could assist the naphthalene catabolic plasmid pND6-1 without any conjugative genes being transferred from P. putida ND6 to Escherichia coli AD256.
Subject(s)
Conjugation, Genetic , Genes, Bacterial , Plasmids/genetics , Pseudomonas putida/genetics , DNA Repair/genetics , DNA Replication , Gene Order , Molecular Sequence Data , Open Reading Frames , Recombination, GeneticABSTRACT
Pseudomonas putida strain ND6 is an efficient naphthalene-degrading bacterium. The complete genome of strain ND6 was sequenced and annotated. The genes encoding the enzymes involved in catechol degradation by the ortho-cleavage pathway were found in the chromosomal sequence, which indicated that strain ND6 is able to metabolize naphthalene by the catechol meta- and ortho-cleavage pathways.
Subject(s)
DNA, Bacterial/chemistry , DNA, Bacterial/genetics , Genome, Bacterial , Pseudomonas putida/genetics , Sequence Analysis, DNA , Biotransformation , Metabolic Networks and Pathways/genetics , Molecular Sequence Data , Naphthalenes/metabolism , Pseudomonas putida/isolation & purification , Pseudomonas putida/metabolismABSTRACT
OBJECTIVE: Thrombolytic therapy is a safe and effective treatment for thrombotic diseases. Microorganisms are possible sources of thrombolytic drugs. We purified and characterized fibrinolytic enzyme produced by Bacillus subtilis strain BS-26. METHODS: We examined the fibrinolytic enzyme activity by fibrin plate and purified fibrinolytic enzyme by ammonium sulfate fractional precipitation, anion-exchange chromatography on DEAE-Sepharose Fast Flow and preparative PAGE. RESULTS: The fibrinolytic enzyme of the strain BS-26 was stable blow 50 degrees C and pH5.0-11.0, the optimal temperature was 42 degrees C and optimal pH was 9.0. Ca2+ and Mg2+ ions enhanced the fibrinolytic activity, whereas Cu2+ completely inhibited the enzyme. Phenylmethylsulfonyl fluoride (174.2 microg/mL), chicken ovomucoid (1000 microg/mL) and soybean trypsin inhibitor (1000 microg/mL) could inhibit enzyme activity, which indicated that the enzyme belonged to serine protease group. On plasminogen-free fibrin plates and plasminogen fibrin plates, the fibrinolytic activity had no obvious difference, indicating that the enzyme was a fibrinolytic enzyme which degraded fibrin directly, but not a plasminogen activator which degraded fibrin by activating plasminogen. A fibrinolytic enzyme was purified from the fermentation broth with recovery yield of 3.2%, purification factor of 41.0 fold and the specific activity 8750.0 U/mg. SDS-PAGE analysis of the purified protein showed only one band with molecular mass of 32 kDa. CONCLUSION: A single fibrinolytic enzyme was purified, which provided the basis for large-scale production of fibrinolytic enzyme.